Chemoinformaics analysis of Fisetin tetramethyl ether
| Molecular Weight | 342.347 | nRot | 5 |
| Heavy Atom Molecular Weight | 324.203 | nRig | 18 |
| Exact Molecular Weight | 342.11 | nRing | 3 |
| Solubility: LogS | -4.875 | nHRing | 1 |
| Solubility: LogP | 3.389 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
| nHA | 6 | APOL | 48.5443 |
| nHD | 0 | BPOL | 27.6057 |
| QED | 0.707 |
| Synth | 2.038 |
| Natural Product Likeliness | 0.432 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.651 |
| MDCK | 0.0000539 |
| BBB | 0.126 |
| PPB | 0.778132 |
| VDSS | 0.854 |
| FU | 0.163916 |
| CYP1A2-inh | 0.699 |
| CYP1A2-sub | 0.973 |
| CYP2c19-inh | 0.806 |
| CYP2c19-sub | 0.837 |
| CYP2c9-inh | 0.711 |
| CYP2c9-sub | 0.921 |
| CYP2d6-inh | 0.14 |
| CYP2d6-sub | 0.941 |
| CYP3a4-inh | 0.84 |
| CYP3a4-sub | 0.644 |
| CL | 5.865 |
| T12 | 0.483 |
| hERG | 0.079 |
| Ames | 0.501 |
| ROA | 0.114 |
| SkinSen | 0.101 |
| Carcinogencity | 0.08 |
| EI | 0.063 |
| Respiratory | 0.106 |
| NR-Aromatase | 0.854 |
| Antiviral | Yes |
| Prediction | 0.858245 |